ARCHIVES

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

This article is from The Cancer Letter archive.

Vol. 32 No. 01 | January 13, 2006

Download PDF Visit The Full Archive

Related Articles

New Cancer Education Grant Program Guidelines, Developed

February 6, 1987

In Brief: Deisseroth Leaves M.D. Anderson To Head Yale’s Oncology, Gene Therapy Programs

September 15, 1995

ACS Board Tables Proposal For Accepting State, Local Funds

December 3, 1993

Core Grant Guideline Revisions, Comprehensive Center Characteristics Changes Still Coming Up

July 13, 1979

Foundation Gives Duke $2M For Brain Tumor Research.

March 23, 2001

Fisher and Redmond Subject Of Misconduct Investigation; ORI

May 6, 1994